Search

everythinglearnresearchcommunity

for

Search:↓

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

The FDA approved a new Pfizer drug for hair loss in teens.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Upadacitinib may cause hair loss.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Ritlecitinib is safe and may effectively treat alopecia areata.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

The rash resolved after stopping ponatinib.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Afatinib often causes skin problems that need proactive management.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.